Richard E Wooley

Author PubWeight™ 7.87^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Location of increased serum survival gene and selected virulence traits on a conjugative R plasmid in an avian Escherichia coli isolate.	Avian Dis	2002	1.13
2	Characterizing avian Escherichia coli isolates with multiplex polymerase chain reaction.	Avian Dis	2004	1.00
3	Prediction of chicken embryo lethality with the avian Escherichia coli traits complement resistance, colicin V production, and presence of the increased serum survival gene cluster (iss).	Avian Dis	2003	0.85
4	Development and evaluation of an experimental model of cutaneous columnaris disease in koi Cyprinus carpio.	J Vet Diagn Invest	2005	0.85
5	Comparison of several challenge models for studies in avian colibacillosis.	Avian Dis	2004	0.84
6	Identification, antimicrobial resistance profiles, and virulence of members from the family Enterobacteriaceae from the feces of yellow-headed blackbirds (Xanthocephalus xanthocephalus) in North Dakota.	Avian Dis	2007	0.81
7	Complement resistance, as determined by viable count and flow cytometric methods, and its association with the presence of iss and the virulence of avian Escherichia coli.	Avian Dis	2002	0.81
8	Comparison of the intravenous chicken challenge method with the embryo lethality assay for studies in avian colibacillosis.	Avian Dis	2003	0.79
9	In vitro and in vivo evaluation of a potentiated miconazole aural solution in chronic Malassezia otitis externa in dogs.	Vet Dermatol	2009	0.79
10	In vitro efficacy of a buffered chelating solution as an antimicrobial potentiator for antifungal drugs against fungal pathogens obtained from horses with mycotic keratitis.	Am J Vet Res	2006	0.75
11	Virulence factors associated with Escherichia coli present in a commercially produced competitive exclusion product.	Avian Dis	2002	0.75
12	Use of potentiated antibiotics in wound management.	Vet Clin North Am Exot Anim Pract	2004	0.75
13	Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro.	Vet Ther	2002	0.75